WU CAPITAL
Wu Capital operates as an investment company. It invests in technology, media, telecom (TMT), healthcare, fintech, high-tech, offline experience consumptions, virtual experience consumptions, culture and Sports, and other related fields. Wu Capital operates business worldwide. It has its headquarters in Beijing in China.
WU CAPITAL
Industry:
Angel Investment FinTech Impact Investing Incubators Trading Platform Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
86 10 84899211
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS DigiCert SSL Pound Sterling Microsoft
Similar Organizations
Anova Capital
Anova Capital focus on investment in education, big health and new consumption.
Current Employees Featured
Rita Zhang CEO @ Wu Capital
CEO
Yunpeng Xia Chief operating officer @ Wu Capital
Chief operating officer
Martin Tian Director of human resources @ Wu Capital
Director of human resources
Alexa Zhang Managing Director / Global Head of Fund Investing @ Wu Capital
Managing Director / Global Head of Fund Investing
2020-01-01
Mingming Li Chief Technology Officer @ Wu Capital
Chief Technology Officer
2020-06-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-05 | Korro Bio | Wu Capital investment in Series B - Korro Bio | 116 M USD |
| 2021-09-23 | RiVAI | Wu Capital investment in Series A - RiVAI | N/A |
| 2021-08-19 | Ranok Therapeutics | Wu Capital investment in Series B - Ranok Therapeutics | 40 M USD |
| 2021-05-31 | Feiliu | Wu Capital investment in Series A - Feiliu | 200 M CNY |
| 2021-04-21 | Laiye | Wu Capital investment in Series C - Laiye | 50 M USD |
| 2021-02-08 | Gemini Therapeutics | Wu Capital investment in Post-IPO Equity - Gemini Therapeutics | 95 M USD |
| 2020-12-21 | Medbanks | Wu Capital investment in Series E - Medbanks | 305 M USD |
| 2020-11-11 | Inipharm | Wu Capital investment in Series A - Inipharm | 35 M USD |
| 2020-09-10 | Korro Bio | Wu Capital investment in Series A - Korro Bio | 91.5 M USD |
| 2020-07-13 | Citrine Medicine | Wu Capital investment in Series A - Citrine Medicine | 80 M USD |
More informations about "Wu Capital"
Wu Capital - Crunchbase Investor Profile & Investments
Wu Capital operates as an investment company. It invests in technology, media, telecom (TMT), healthcare, fintech, high-tech, offline experience consumptions, virtual experience consumptions, culture and Sports, and other related fields. …See details»
Wu Capital - Investments, Portfolio & Company Exits - Crunchbase
Jan 5, 2022 Wu Capital 's most notable exits include Korro Bio, Horizon Robotics, and Semma Therapeutics. Which industries has this organization had the most exits in? Show . Korro Bio …See details»
Wu Capital - Investor Profile, Portfolio & Team - Tracxn
Feb 10, 2025 Co-investors of Wu Capital. Over the past . 9 years, 183 investors have co-invested in Wu Capital's portfolio companies.. This includes funds and angels.Invested before …See details»
List of top Wu Capital Portfolio Companies - Crunchbase
Wu Capital focuses on investments in healthcare, consumer, high-tech, and education. This list of organizations invested in by Wu Capital provides data on their funding history, investment …See details»
Wu Capital - CB Insights
Aug 20, 2021 Wu Capital is a family office that focuses on investments in technology, media & entertainment, and telecommunications (TMT), healthcare, consumer, fintech, high-tech, and …See details»
Wu Capital - Golden
Wu Capital is a family investment office in Beijing that focuses on investments in healthcare, consumer, high-tech, and education. Founded 2013 in Beijing, China, it invests in series B, …See details»
Wu Capital - Company Profile and News - Bloomberg Markets
Company profile page for Wu Capital including stock price, company news, executives, board members, and contact informationSee details»
Platanus (Wu Capital) - Family Office, China - SWFI
Beijing Shuanghu Investment Management Co., Ltd. (Wu Capital) is a Family Office located in Beijing China, Asia. Current Assets for Wu Capital is $12,700,000,000 and SWFI has 1 …See details»
Wu Capital - General Family Offices - Future Family Office
Wu Capital operates as an investment company. It invests in technology, media, telecom (TMT), healthcare, fintech, high-tech, offline experience consumptions, virtual experience …See details»
Wu Capital - Private Equity List
Wu Capital operates as an investment company. The Company invests in technology, media, telecom (TMT), healthcare, fintech, high-tech, offline experience consumptions, virtual …See details»
Wu Capital - CompassList
Founded in 2013 by board chairman of Longfor Properties Wu Yajun, Wu Capital conducts multistages investments and focuses on TMT, healthcare, fintech, consumption, culture and …See details»
双湖资本：让家族办公室成为连接一切创新的新物种 | LP怎么看-36氪
但他们记住了这个极具东方色彩的名字：Wu Capital（双湖资本）。 正如双湖的英文名所昭示的——不同于中国市面上的传统出资人，站在它背后的是 ...See details»
Wu Capital （双湖资本） Information - RocketReach
The Wu Capital （双湖资本） annual revenue was $5.4 million in 2025. Who is the COO of Wu Capital （双湖资本）? Yunpeng Xia is the COO of Wu Capital （双湖资本）. How many …See details»
双湖投资_北京双湖投资管理有限公司_投资家网
双湖投资（Wu Capital）是一家龙湖地产董事长吴亚军女士创立的家族办公室，成立于2013年4月，业务覆盖FOF母基金、一级市场直投、二级市场投资等。聚焦TMT、医疗健康、酷科技、新 …See details»
Should you work with Wu Capital? Read this first!
Description - 双湖资本成立于2013年，是中国大陆最早的机构化、专业化管理的家族办公室之一。. Investor Type - VCSee details»
WU CAPITAL LTD Schedule 13G Filing Concerning NAMI on 2024 …
Feb 14, 2025 Wu Capital Limited: 13.93% Xinyi Cai: 13.93% The percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of …See details»
Wu Capital’s CEO on China’s PE Industry, Trends, Tech Startups
Mar.21 -- Rita Zhang, chief executive officer at Wu Capital, discusses the outlook for valuations of startups in China, the private equity industry in China, the trend to invest in Chinese tech …See details»
双湖资本：让家族办公室成为连接一切创新的新物种-美通社PR-Ne…
Apr 19, 2019 2013年的夏天，对于美国的基金管理人来说，这仍是一群来自中国的陌生访客。但他们记住了这个极具东方色彩的名字：Wu Capital（双湖资本）。 正如双湖的英文名所昭示的 …See details»
The impact of organization capital on firm innovation
Apr 1, 2021 The motivation to explain innovation using organization capital is consistent with the view of Porter (1992, p. 65) that “Innovation and upgrading come from sustained investment in …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»